# Ameriserv Financial Inc: financial statements, quarterly

ASRV · Nasdaq · CIK 707605 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/asrv.md) · [Financials](/companies/asrv/financials.md) · [Filings](/companies/asrv/filings.md) · [Insiders](/companies/asrv/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/asrv/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [3,710](/filings/0001558370-24-015314.md) | [3,713 d](/filings/0001558370-25-003291.md) | [4,058](/filings/0001558370-25-007547.md) | [3,872](/filings/0001558370-25-011060.md) | [3,879](/filings/0001104659-25-111219.md) | [3,810 d](/filings/0001104659-26-031270.md) | [3,470](/filings/0001104659-26-061052.md) | [3,601](/filings/0001104659-26-096940.md) | [3,660](/filings/0001104659-25-111219.md) | [3,903 d](/filings/0001104659-26-031270.md) | [3,611](/filings/0001104659-26-061052.md) | [3,871](/filings/0001104659-26-096940.md) |
| Interest expense | $k | [6,640](/filings/0001558370-24-015314.md) | [7,379](/filings/0001558370-24-004100.md) | [7,477](/filings/0001558370-25-007547.md) | [7,635](/filings/0001558370-25-011060.md) | [7,821](/filings/0001104659-25-111219.md) | [7,524 d](/filings/0001104659-26-031270.md) | [7,091](/filings/0001104659-26-061052.md) | [7,295](/filings/0001104659-26-096940.md) | [7,476](/filings/0001104659-25-111219.md) | [7,229 d](/filings/0001104659-26-031270.md) | [6,674](/filings/0001104659-26-061052.md) | [6,763](/filings/0001104659-26-096940.md) |
| Income tax | $k | [124](/filings/0001558370-25-003291.md) | [(1,477)](/filings/0001558370-25-003291.md) | [483](/filings/0001104659-26-031270.md) | [(109)](/filings/0001104659-26-031270.md) | [237](/filings/0001104659-26-031270.md) | [187](/filings/0001104659-26-031270.md) | [478](/filings/0001104659-26-061052.md) | [(70.0)](/filings/0001104659-26-096940.md) | [540](/filings/0001104659-26-031270.md) | [236](/filings/0001104659-26-031270.md) | [426](/filings/0001104659-26-061052.md) | [661](/filings/0001104659-26-096940.md) |
| Net income | $k | [647](/filings/0001558370-25-003291.md) | [(5,321)](/filings/0001558370-25-003291.md) | [1,904](/filings/0001104659-26-031270.md) | [(375)](/filings/0001104659-26-031270.md) | [1,183](/filings/0001104659-26-031270.md) | [889](/filings/0001104659-26-031270.md) | [1,908](/filings/0001104659-26-061052.md) | [(282)](/filings/0001104659-26-096940.md) | [2,544](/filings/0001104659-26-031270.md) | [1,442](/filings/0001104659-26-031270.md) | [1,794](/filings/0001104659-26-061052.md) | [2,738](/filings/0001104659-26-096940.md) |
| Diluted EPS | $ per share | [0.04](/filings/0001558370-25-003291.md) | [(0.31)](/filings/0001558370-25-003291.md) | [0.11](/filings/0001104659-26-031270.md) | [(0.02)](/filings/0001104659-26-031270.md) | [0.07](/filings/0001104659-26-031270.md) | [0.05](/filings/0001104659-26-031270.md) | [0.12](/filings/0001104659-26-061052.md) | [(0.02)](/filings/0001104659-26-096940.md) | [0.15](/filings/0001104659-26-031270.md) | [0.09](/filings/0001104659-26-031270.md) | [0.11](/filings/0001104659-26-061052.md) | [0.16](/filings/0001104659-26-096940.md) |
| Basic EPS | $ per share | [0.04](/filings/0001558370-25-003291.md) | [(0.31)](/filings/0001558370-25-003291.md) | [0.11](/filings/0001104659-26-031270.md) | [(0.02)](/filings/0001104659-26-031270.md) | [0.07](/filings/0001104659-26-031270.md) | [0.05](/filings/0001104659-26-031270.md) | [0.12](/filings/0001104659-26-061052.md) | [(0.02)](/filings/0001104659-26-096940.md) | [0.15](/filings/0001104659-26-031270.md) | [0.09](/filings/0001104659-26-031270.md) | [0.11](/filings/0001104659-26-061052.md) | [0.16](/filings/0001104659-26-096940.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [1,362](/filings/0001558370-23-018535.md) | [1,390](/filings/0001558370-25-003291.md) | [1,385](/filings/0001558370-24-007970.md) | [1,403](/filings/0001558370-24-011888.md) | [1,405](/filings/0001558370-24-015314.md) | [1,422](/filings/0001104659-26-031270.md) | [1,432](/filings/0001558370-25-007547.md) | [1,449](/filings/0001558370-25-011060.md) | [1,461](/filings/0001104659-25-111219.md) | [1,454](/filings/0001104659-26-096940.md) | [1,473](/filings/0001104659-26-061052.md) | [1,462](/filings/0001104659-26-096940.md) |
| Total liabilities | $m | [1,260](/filings/0001558370-23-018535.md) | [1,287](/filings/0001558370-25-003291.md) | [1,281](/filings/0001558370-24-007970.md) | [1,300](/filings/0001558370-24-011888.md) | [1,297](/filings/0001558370-24-015314.md) | [1,315](/filings/0001104659-26-031270.md) | [1,321](/filings/0001558370-25-007547.md) | [1,338](/filings/0001558370-25-011060.md) | [1,347](/filings/0001104659-25-111219.md) | [1,335](/filings/0001104659-26-096940.md) | [1,352](/filings/0001104659-26-061052.md) | [1,339](/filings/0001104659-26-096940.md) |
| Short-term borrowings | $m | [63.5](/filings/0001558370-23-018535.md) | [41.0](/filings/0001558370-25-003291.md) | [11.4](/filings/0001558370-24-007970.md) | [34.6](/filings/0001558370-24-011888.md) | [11.8](/filings/0001558370-24-015314.md) | [14.6](/filings/0001104659-26-031270.md) | [10.4](/filings/0001558370-25-007547.md) | [2.7](/filings/0001558370-25-011060.md) | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [101](/filings/0001558370-24-015314.md) | [102](/filings/0001104659-26-031270.md) | [104](/filings/0001558370-25-011060.md) | [104](/filings/0001104659-25-111219.md) | [108](/filings/0001104659-25-111219.md) | [107](/filings/0001104659-26-096940.md) | [111](/filings/0001104659-26-096940.md) | [111](/filings/0001104659-26-096940.md) | [115](/filings/0001104659-25-111219.md) | [119](/filings/0001104659-26-096940.md) | [121](/filings/0001104659-26-096940.md) | [123](/filings/0001104659-26-096940.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [2,684 d](/filings/0001558370-24-015314.md) | [1,110 d](/filings/0001558370-25-003291.md) | [(2,152)](/filings/0001558370-25-007547.md) | [1,702 d](/filings/0001558370-25-011060.md) | [(235) d](/filings/0001104659-25-111219.md) | [3,372 d](/filings/0001104659-26-031270.md) | [599](/filings/0001104659-26-061052.md) | [(62.0) d](/filings/0001104659-26-096940.md) | [1,404 d](/filings/0001104659-25-111219.md) | [1,246 d](/filings/0001104659-26-031270.md) | [356](/filings/0001104659-26-061052.md) | [(1,115) d](/filings/0001104659-26-096940.md) |
| Dividends paid | $k | [513 d](/filings/0001558370-24-015314.md) | [516 d](/filings/0001558370-25-003291.md) | [514](/filings/0001558370-25-007547.md) | [515 d](/filings/0001558370-25-011060.md) | [495 d](/filings/0001104659-25-111219.md) | [496 d](/filings/0001104659-26-031270.md) | [496](/filings/0001104659-26-061052.md) | [495 d](/filings/0001104659-26-096940.md) | [495 d](/filings/0001104659-25-111219.md) | [496 d](/filings/0001104659-26-031270.md) | [508](/filings/0001104659-26-061052.md) | [510 d](/filings/0001104659-26-096940.md) |
| Share repurchases | $k | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001104659-25-111219.md) | [0.0 d](/filings/0001104659-26-031270.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [17.1](/filings/0001558370-23-018535.md) | [17.2](/filings/0001558370-24-007970.md) | [17.1](/filings/0001558370-24-011888.md) | [17.1](/filings/0001558370-24-015314.md) | [17.1](/filings/0001558370-25-007547.md) | [17.0](/filings/0001558370-25-011060.md) | [16.5](/filings/0001104659-25-111219.md) | [16.5](/filings/0001104659-26-061052.md) | [16.5](/filings/0001104659-26-096940.md) | [16.5](/filings/0001104659-25-111219.md) | [16.9](/filings/0001104659-26-061052.md) | [17.0](/filings/0001104659-26-096940.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 16,979,267 at 2026-08-10, from the cover of the [10-Q filed 2026-08-14](/filings/0001104659-26-096940.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.